Example: Heart Attack

Clinical Trials on Amphetamine-Related Disorders

Total 51 results

    • NCT04203654
      Recruiting
      Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model
      Conditions: Amphetamine-Related Disorders
    • NCT02232789
      Completed
      Abuse Liability and Human Pharmacology of Mephedrone
      Conditions: Amphetamine-Related Disorders
    • NCT01899313
      Unknown status
      A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence
      Conditions: Amphetamine-Related Disorders
    • NCT01888835
      Completed
      Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
      Conditions: Amphetamine-Related Disorders
    • NCT01449565
      Completed
      Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)
      Conditions: Amphetamine-Related Disorders
    • NCT00158197
      Completed
      Long-term Behavior Change - 1
      Conditions: Amphetamine-related Disorders
    • NCT00267657
      Unknown status
      A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00265278
      Unknown status
      Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00254306
      Completed
      Functional Brain Imaging in Recreational Users of Ecstasy
      Conditions: Amphetamine-Related Disorders
    • NCT00100074
      Unknown status
      To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00089440
      Unknown status
      Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00069251
      Completed
      Bupropion for the Treatment of Methamphetamine Dependence - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00040053
      Completed
      Ondansetron for the Treatment of Methamphetamine Dependence - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00040040
      Unknown status
      Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00033072
      Unknown status
      Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00000322
      Completed
      Tyrosine for Methamphetamine Dependence - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00000351
      Unknown status
      Cognitive Correlates of Substance Abuse, Part 2 - 16
      Conditions: Amphetamine-Related Disorders
    • NCT00000346
      Unknown status
      Cognitive Correlates of Substance Abuse - 11
      Conditions: Amphetamine-Related Disorders
    • NCT01296802
      Completed
      Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
      Conditions: Amphetamine-Related Disorders; Amphetamine Abuse
    • NCT02294266
      Completed
      Mephedrone and Alcohol Interactions in Humans
      Conditions: Amphetamine-Related Disorders; Alcohol-Related Disorders
    • NCT00000350
      Unknown status
      Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
      Conditions: Amphetamine-Related Disorders; Tobacco Use Disorder
    • NCT00856323
      Completed
      Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men
      Conditions: Amphetamine-Related Disorders; HIV; HIV Infections
    • NCT03902405
      Recruiting
      Computerized Exercise to Alter Stimulant Approach Responses
      Conditions: Amphetamine-Related Disorders; Cocaine-Related Disorders; Substance-Related Disorders
    • NCT01386177
      Completed
      Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)
      Conditions: Mood Disorder; Substance-Related Disorders; Amphetamine-Related Disorders
    • NCT01270672
      Completed
      Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
      Conditions: Mood Disorder; Substance-Related Disorders; Amphetamine-Related Disorders
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations